Equippp Social Impact Technologies Ltd
NSE: EQUIPPP BSE: 590057
₹17.96
(-3.60%)
Wed, 25 Mar 2026, 09:22 am
Market Cap1.86B
PE Ratio105.03
Dividend0
Technology Services
Internet Software/Services
24.5KEquippp Social Impact Technologies Analysis
dividend
- Unable to calculate sustainability of dividends as Proseed India has not reported any payouts.
- Unable to evaluate Proseed India's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Proseed India's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Low level of unsold assets.
- Proseed India's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Proseed India has less than a year of cash runway if free cash flow continues to grow at historical rates of 39.9% each year.
- Proseed India has less than a year of cash runway based on current free cash flow.
- Operating cash flow is negative therefore debt is not well covered.
- Proseed India has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
- Proseed India's long term commitments exceed its cash and other short term assets.
- Irrelevant to check if Proseed India's debt level has increased considering it has negative shareholder equity.
- Proseed India has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
management
- Dasigi Venkata Surya's remuneration is lower than average for companies of similar size in India.
- Dasigi Venkata Surya's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Proseed India board of directors is less than 3 years, this suggests a new board.
misc
- Proseed India is not covered by any analysts.
- Proseed India has significant price volatility in the past 3 months.
past
- Unable to compare Proseed India's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Proseed India does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
- It is difficult to establish if Proseed India has efficiently used its assets last year compared to the IN Biotechs industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Proseed India improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
- It is difficult to establish if Proseed India has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
- Unable to compare Proseed India's 1-year growth to the Asia Biotechs industry average as it is not currently profitable.
value
- BSE:590057 is up 26.1% outperforming the Biotechs industry which returned 18.2% over the past month.
- BSE:590057 is up 26.1% outperforming the market in India which returned 8% over the past month.
- Proseed India has negative assets, we can't compare the value of its assets to the IN Biotechs industry average.
- Proseed India is loss making, we can't compare its value to the IN Biotechs industry average.
- Proseed India is loss making, we can't compare the value of its earnings to the India market.
- 590057 underperformed the Biotechs industry which returned 53.2% over the past year.
- 590057 underperformed the Market in India which returned -14.5% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800